TAK Q1 2026 Earnings SmallerThanExpected Loss Fails to Lift Shares Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines GBLI Q1 2026 Earnings Significant EPS Miss Underscores Underwriting Challenges TT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher BWNB Q1 2026 Earnings Significant EPS Miss Highlights Persistent Cost Pressures ArcBest ARCB Q1 2026 Earnings EPS Surges Past Estimates in Modest Volume Environment